Page last updated: 2024-09-05

org 31710 and cyclin d1

org 31710 has been researched along with cyclin d1 in 1 studies

Compound Research Comparison

Studies (org 31710)	Trials (org 31710)	Recent Studies (post-2010) (org 31710)	Studies (cyclin d1)	Trials (cyclin d1)	Recent Studies (post-2010) (cyclin d1)
38	3	6	10,885	70	5,157

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cornish, AL; Lee, CS; Musgrove, EA; Sutherland, RL; Swarbrick, A	1

Other Studies

1 other study(ies) available for org 31710 and cyclin d1

Article	Year
Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:1 Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Drug Resistance; Estrenes; Furans; Hormone Antagonists; Humans; Mifepristone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogene Proteins; Phosphorylation; Progestins; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Retinoblastoma Protein; Tumor Cells, Cultured	1997

Article

Year

Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21.

Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:1

Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Drug Resistance; Estrenes; Furans; Hormone Antagonists; Humans; Mifepristone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogene Proteins; Phosphorylation; Progestins; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Retinoblastoma Protein; Tumor Cells, Cultured

1997